Greenway loses $134,975 in fiscal Q3

Mr. Jamie D'Alimonte reports GREENWAY ANNOUNCES THIRD QUARTER FINANCIAL STATEMENTS Greenway Greenhouse Cannabis Corp. today filed its unaudited condensed interim financial statements for the three and nine months ended Dec. 31, 2025. Highlights for the third quarter ended Dec. 31, 2025. All amounts are expressed in Canadian dollars: Net cannabis revenue was $2,348,797 (fiscal Q3 2025: $1,676,721), an increase of $672,076 (40 per cent), with an average net sales price per gram of $1.51 (fiscal Q3 2025: $1.58). Net cannabis revenue for the nine months ended Dec. 31, 2025, increased to $6,062,528 (2025 of $5,877,837). Cash cost per gram sold decreased to 92 cents (fiscal Q3 2025: $1.03). Gross profit improved to $680,589 (fiscal Q3 2025: $249,197) in the quarter. For the 2026 fiscal year, gross profit totals $2,321,996, representing more than a 350-per-cent increase compared to the prior year. Gross margin improved to 29 per cent (fiscal Q3 2025: 15 per cent). The company generated positive operating income for the fourth consecutive quarter. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $399,738 (fiscal Q3 2025: $85,758) an increase of $313,980, representing the fifth consecutive quarter of positive adjusted EBITDA. Finished goods inventory totaled 3,053,665 grams valued at $3,377,433, supporting anticipated customer demand requirements. Cash was $1,181,770 at quarter-end; working capital (excluding amounts due to related parties) amounted to $5,819,285. Jamie D'Alimonte, chief executive officer of Greenway, said: "We are pleased to report our Q3 results which delivered revenue growth of 40 per cent year over year, expanding margins and our fifth consecutive quarter of positive adjusted EBITDA. Our quarter-end cash plus the value of finished goods inventory total more than $4.5-million, giving us a healthy working capital position and inventory to support anticipated demand for our high-quality product. Our results reflect a business that is gaining scale, improving unit economics and strengthening strategic customer relationships. "Our objective is clear: to build a resilient, high-quality cannabis platform capable of generating consistent returns through industry cycles." "Our production team was able to reduce cash cost per gram over 10 per cent, to 92 cents, from $1.03 a year ago. We are demonstrating that disciplined execution in this market drives durable results," said Carl Mastronardi, president of Greenway. "As we move forward, our focus remains on scaling production efficiently, optimizing yields and enhancing product mix to ensure we continue building momentum across the platform." Issuance of shares The company is pleased to announce that, pursuant to its engagement letter dated June 4, 2024, with Abingdon Capital Corp., an arm's-length consultant, the company has issued the consultant and its assignees an aggregate of 402,549 common shares in the capital of the company at deemed prices between 15 cents and 25 cents per common share. The common shares were issued in satisfaction of a portion of the monthly work fee owed to the consultant as consideration for the provision of corporate-finance advisory services. All common shares issued will be subject to a hold period of four months and a day from the date of issuance in accordance with applicable Canadian Securities Exchange policies and Canadian securities laws. A copy of the interim financial statements for the quarter ended Dec. 31, 2025 (prepared in accordance with international financial reporting standards accounting standards (IFRS)) and the related management's discussion and analysis are available under the company's profile on SEDAR+. About Greenway Greenhouse Cannabis Corp. Greenway Greenhouse Cannabis is a federally licensed cultivator for the Canadian cannabis marketplace. Greenway is headquartered in Kingsville, Ont., and leverages its agriculture and cannabis expertise in its aspiration to be a leading cannabis cultivator in Canada. We seek Safe Harbor.